INS and type 2 diabetes mellitus: Following the utilization of PPARγ agonists for type 2 diabetes mellitus in improving insulin sensitivity, the pleiotropic effects of PPARγ in neurodegenerative diseases like AD have been increasingly investigated in recent years.